SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-043668
Filing Date
2019-11-18
Accepted
2019-11-18 07:16:42
Documents
13
Period of Report
2019-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 101319 alks-8k_20191114.htm   iXBRL 8-K 49523
2 EX-99.1 alks-ex991_33.htm EX-99.1 30997
  Complete submission text file 0001564590-19-043668.txt   221405

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20191114.xsd EX-101.SCH 5968
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20191114_lab.xml EX-101.LAB 19413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20191114_pre.xml EX-101.PRE 11606
9 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20191114_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 191226144
SIC: 2834 Pharmaceutical Preparations